人工智能系统判定T1结直肠癌淋巴结转移风险
研究基于日本6家医院3134例T1结直肠癌患者构建人工神经网络模型,并在另一家医院939例患者中外部验证。验证队列中模型识别淋巴结转移的AUC为0.83,指南为0.73(P < .001);内镜切除亚组中模型AUC为0.84,指南为0.77(P = .005)。模型优于指南。
要点
- 验证队列中人工神经网络模型识别淋巴结转移AUC为0.83,指南为0.73(P < .001)。
- 内镜切除亚组中模型AUC为0.84,指南为0.77(P = .005)。
- 模型可能用于判定T1结直肠癌内镜切除后哪些患者需追加手术。
核心结论
- 人工神经网络模型在识别T1结直肠癌淋巴结转移方面优于指南。
- 该模型可能用于判定T1结直肠癌内镜切除后哪些患者需要追加手术。
研究设计与样本
- 训练队列为1997年4月至2017年9月日本6家医院治疗的3134例T1结直肠癌患者。
- 采用患者年龄、性别、肿瘤大小、部位、形态、淋巴管和血管侵犯及组织学分级数据构建机器学习人工神经网络。
- 验证队列为同期另一家医院独立939例患者,进行外部验证。
- 计算模型与美国指南识别淋巴结转移的受试者工作特征曲线下面积(AUC)。
主要发现
- 训练队列3134例中319例(10.2%)发现淋巴结转移。
- 验证队列939例中79例(8.4%)发现淋巴结转移。
- 验证队列中模型识别淋巴结转移AUC为0.83,指南为0.73(P < .001)。
- 限内镜切除患者(n = 517)时,模型AUC为0.84,指南为0.77(P = .005)。
临床怎么用
- 作者认为该模型可能用于判定T1结直肠癌内镜切除后哪些患者需要追加手术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: In accordance with guidelines, most patients with T1 colorectal cancers (CRC) undergo surgical resection with lymph node dissection, despite the low incidence (∼10%) of metastasis to lymph nodes. To reduce unnecessary surgical resections, we used artificial intelligence to build a model to identify T1 colorectal tumors at risk for metastasis to lymph node and validated the model in a separate set of patients. METHODS: We collected data from 3134 patients with T1 CRC treated at 6 hospitals in Japan from April 1997 through September 2017 (training cohort). We developed a machine-learning artificial neural network (ANN) using data on patients' age and sex, as well as tumor size, location, morphology, lymphatic and vascular invasion, and histologic grade. We then conducted the external validation on the ANN model using independent 939 patients at another hospital during the same period (validation cohort). We calculated areas under the receiver operator characteristics curves (AUCs) for the ability of the model and US guidelines to identify patients with lymph node metastases. RESULTS: Lymph node metastases were found in 319 (10.2%) of 3134 patients in the training cohort and 79 (8.4%) of /939 patients in the validation cohort. In the validation cohort, the ANN model identified patients with lymph node metastases with an AUC of 0.83, whereas the guidelines identified patients with lymph node metastases with an AUC of 0.73 (P < .001). When the analysis was limited to patients with initial endoscopic resection (n = 517), the ANN model identified patients with lymph node metastases with an AUC of 0.84 and the guidelines identified these patients with an AUC of 0.77 (P = .005). CONCLUSIONS: The ANN model outperformed guidelines in identifying patients with T1 CRCs who had lymph node metastases. This model might be used to determine which patients require additional surgery after endoscopic resection of T1 CRCs. UMIN Clinical Trials Registry no: UMIN000038609.
引用
- Kudo SE, Ichimasa K, Villard B, et al. Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node. Gastroenterology. 2020. PMID: 32979355. doi:10.1053/j.gastro.2020.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。